Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cyclo(-l-threonyl-l-tryptophanyl-l-isoleucyl-l-2,4-diaminobutyryl-l-ornithyl-d-2,4-diaminobutyryl-l-2,4-diaminobutyryl-l-tryptophanyl-l-2,4-diaminobutyryl-l-2,4-diaminobutyryl-l-alanyl-l-seryl-d-prolyl-l-prolyl), Acetate Salt
2. Pol7080
1. 944252-63-5
2. Murepavadin [inn]
3. Pol7080
4. Ro7033877
5. 0d02gry87z
6. Ro-7033877
7. Pol-7080
8. Cyclo(l-alanyl-l-seryl-d-prolyl-l-prolyl-l-threonyl-l-tryptophyl-l-isoleucyl-(2s)-2,4-diaminobutanoyl-l-ornithyl-(2r)-2,4-diaminobutanoyl-(2s)-2,4-diaminobutanoyl-l-tryptophyl-(2s)-2,4-diaminobutanoyl-(2s)-2,4-diaminobutanoyl)
9. Unii-0d02gry87z
10. Murepavadin (usan/inn)
11. Murepavadin [usan:inn]
12. Murepavadin [usan]
13. Murepavadin [who-dd]
14. Chembl3946483
15. Gtpl10832
16. Ex-a4063
17. Rg7929
18. Akos037648482
19. Db14777
20. Rg-7929
21. Bs-14122
22. D10957
23. D80443
24. Q27236621
| Molecular Weight | 1553.8 g/mol |
|---|---|
| Molecular Formula | C73H112N22O16 |
| XLogP3 | -4.1 |
| Hydrogen Bond Donor Count | 22 |
| Hydrogen Bond Acceptor Count | 22 |
| Rotatable Bond Count | 21 |
| Exact Mass | 1552.86266557 g/mol |
| Monoisotopic Mass | 1552.86266557 g/mol |
| Topological Polar Surface Area | 618 Ų |
| Heavy Atom Count | 111 |
| Formal Charge | 0 |
| Complexity | 3200 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 16 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Murepavadin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Murepavadin, including repackagers and relabelers. The FDA regulates Murepavadin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Murepavadin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Murepavadin supplier is an individual or a company that provides Murepavadin active pharmaceutical ingredient (API) or Murepavadin finished formulations upon request. The Murepavadin suppliers may include Murepavadin API manufacturers, exporters, distributors and traders.
Murepavadin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Murepavadin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Murepavadin GMP manufacturer or Murepavadin GMP API supplier for your needs.
A Murepavadin CoA (Certificate of Analysis) is a formal document that attests to Murepavadin's compliance with Murepavadin specifications and serves as a tool for batch-level quality control.
Murepavadin CoA mostly includes findings from lab analyses of a specific batch. For each Murepavadin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Murepavadin may be tested according to a variety of international standards, such as European Pharmacopoeia (Murepavadin EP), Murepavadin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Murepavadin USP).
LOOKING FOR A SUPPLIER?
